<DOC>
	<DOC>NCT00584961</DOC>
	<brief_summary>To assess the prevalence of Metabolic Syndrome in Spanish population with Bipolar I or II Disorder. To analyse the clinical progress disease in patients with Bipolar I or II Disorder for 12 months using the assessment of the symptoms disease and the progress of metabolic and cardiovascular risk. To analyse the health status, quality of life and functioning/disability of patients.</brief_summary>
	<brief_title>BIMET Study: Evolution of Metabolic and Cardiovascular Risks Factors in Patients With Bipolar Disorder</brief_title>
	<detailed_description>Consecutive patient sampling. In any investigational site, five consecutive patients with diagnosis of Bipolar Disorder will be enrolled in the study</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<criteria>Patients with diagnosis of Bipolar Disorder (DSMIV TR) Patients or their legal representatives have provided informed consent Patients are unable to complete or to understand health questionnaires in Spanish language Patients enrolled in clinical trials or other studies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2010</verification_date>
	<keyword>Metabolic Syndrome, Bipolar Disorder and Cardiovascular Risk Factors</keyword>
</DOC>